Buffett wades into Japan, NASDAQ hits record high, ASX futures down 58 points

Published 01-SEP-2020 09:53 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

After being in positive territory for most of Monday, the S&P/ASX 200 index (XJO) fell away in the last hour to close down 13 points at 6061 points.

The big four banks all finished in the red, and given their index weightings that would have been enough to drive the XJO into negative territory.

With most overseas markets falling overnight the ASX could be set to deliver its third consecutive day of losses, and the ASX SPI200 index is certainly pointing in that direction, down 58 points to 5972 points.

24 hours

Japan dominated news in the Asia-Pacific yesterday, and this was largely responsible for the outperformance of its markets with the Nikkei 225 the only major index in that region to finish in the black.

A key development was the announcement by Warren Buffett’s Berkshire Hathaway that it had acquired stakes of at least 5% in five leading Japanese stocks with his investment valued at approximately US$6 billion.

Most of the companies are household names - Itochu Corp., Marubeni Corp., Mitsubishi Corp., Mitsui & Co., and Sumitomo Corp.

They are largely involved in importing a range of commodities into Japan including metals, energy and consumer goods, seemingly a solid strategy given the resource starved country is heavily reliant on imports.

Many in the market would see this as another Buffett masterclass, suggesting we should see further money flowing into Japan.

Meanwhile, the Nikkei 225 gained 257 points or 1.1% to close at 23,139 points.

The Hang Seng and the Shanghai Composite fell 1% and 0.2% respectively, closing at 25,177 points and 3395 points.

The mood was decidedly negative in Europe with the FTSE 100 coming off 36 points to close at 5963 points, a decline of 0.6%.

The DAX also finished down about 0.6% at 12,945 points, while the CAC 40 experienced a stronger sell-off as it closed down 1.1% at 4947 points.

In the US, the S&P 500 finally took a breather as it shed 0.2% to close at 3500 points.

The Dow fell 223 points or 0.8% to 28,430 points, but the ever resilient NASDAQ finished up 80 points despite a significant sell down in the last half hour of trading.

However, this wasn’t before the juggernaut had notched up another record high of 11,829 points.

The Brent Crude Oil Continuous Contract started the day strongly, increasing more than 1% to hit US$46.53 per barrel, but all of these gains plus some were lost in the afternoon before it closed in the vicinity of US$45.50 per barrel.

While gold had a relatively flat day, it consolidated last week’s gain of about US$50 per ounce to finish close to US$1980 per ounce.

Iron ore increased marginally to US$124.50 per tonne.

There was little movement in copper and nickel prices, although the latter is now less than 1% shy of US$7.00 per pound, a level it hasn’t traded at since 2019.

Lead was flat while zinc gained nearly 2% to finish at US$1.15 per pound - it looks increasingly likely to push up to mid-2019 levels of US$1.20 per pound.

The Australian dollar continued to strengthen against the US dollar, falling just shy of US$0.74.

The announcement in the US of fiscal stimulus packages appears imminent, a development that would place downward pressure on the US dollar.

It appears that currency traders have already started to factor in this scenario.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X